Products
Applications
Company
Contact
EN
EN
- Global
CN
- 中国
menu
Close
Home
Products
System
Panels
Applications
Pharmacogenetics
Liquid Biopsy
Mutation Profiling
Hereditary Genetics
Methylation
Sample Integrity
Specimen Validity
Services
Assays by Agena
Certified Service Providers
Resources
Product Literature
Publication Library
Support
Service Plans
Distributors
Certified Service Providers
Company
Careers
Press
Contact
Customer Support Portal
Home
Products
System
Panels
Applications
Pharmacogenetics
Mutation Profiling
Liquid Biopsy
Hereditary Genetics
Methylation
Sample Integrity
Specimen Validity
Services
Assays by Agena
Certified Service Providers
Resources
Product Literature
Publication Library
Support
Service Plans
Distributors
Certified Service Providers
Company
Careers
Press
Contact
Customer Support Portal
Phone: (858) 882-2800
Home
/
Resources
/
Publication Library
Search Results for: Mutation Profiling
Search All publications
How recent?
Search
Molecular characterization of lung squamous cell carcinoma tumors reveals therapeutically relevant alterations
Relationship between PD-L1 expression and outcome in EGFR-mutant lung cancer patients treated with EGFR tyrosine kinase inhibitors
Molecular profiling of appendiceal serrated lesions, polyps and mucinous neoplasms: a single-centre experience
Clinical Utility of Reflex Ordered Testing for Molecular Biomarkers in Lung Adenocarcinoma
Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responses
Diagnostic yield of colonoscopy surveillance in testicular cancer survivors treated with platinum-based chemotherapy: study protocol of a prospective cross-sectional cohort study
RAS as a positive predictive biomarker: focus on lung and colorectal cancer patients
Genomic and evolutionary portraits of disease relapse in acute myeloid leukemia
A case series of extraneural metastatic glioblastoma at Memorial Sloan Kettering Cancer Center
Diverse mechanisms activate the PI 3-kinase/mTOR pathway in melanomas: implications for the use of PI 3-kinase inhibitors to overcome resistance to inhibitors of BRAF and MEK
«
...
7
8
9
10
11
...
20
30
40
...
»